[Management of ocular toxoplasmosis in France: Results of a modified Delphi study]

J Fr Ophtalmol. 2022 Apr;45(4):413-422. doi: 10.1016/j.jfo.2021.11.007. Epub 2022 Jan 30.
[Article in French]

Abstract

Objective: To evaluate diagnostic and therapeutic practices and then establish a consensus on the management of ocular toxoplasmosis in France through a Delphi study.

Materials and methods: Twenty-three French experts in ocular toxoplasmosis were invited to respond to a modified Delphi study conducted online, in the form of two questionnaires, in an attempt to establish a consensus on the diagnosis and management of this pathology. The threshold for identical responses to reach consensus was set at 70 %.

Results: The responses of 19 experts out of the 23 selected were obtained on the first questionnaire and 16 experts on the second. The main elements agreed upon by the experts were to treat patients with a decrease in visual acuity or an infectious focus within the posterior pole, to treat peripheral lesions only in the presence of significant inflammation, the prescription of first-line treatment with pyrimethamine-azithromycin, the use of corticosteroid therapy after a period of 24 to 48hours, the prophylaxis of frequent recurrences (more than 2 episodes per year) with trimethoprim-sulfamethoxazole as well as the implementation of prophylactic treatment of recurrences in immunocompromised patients. On the other hand, no consensus emerged with regard to the examinations to be carried out for the etiological diagnosis (anterior chamber paracentesis, fluorescein angiography, serology, etc.), second-line treatment (in the case of failure of first-line treatment), or treatment of peripheral foci.

Conclusion: This study lays the foundations for possible randomized scientific studies to be conducted to clarify the management of ocular toxoplasmosis, on the one hand to confirm consensual clinical practices and on the other hand to guide practices for which no formal consensus has been demonstrated.

Keywords: Anti-inflammatoire; Anti-inflammatory; Anti-parasitic; Antiparasitaire; Delphi method; Delphi study; Ocular toxoplasmosis; Toxoplasmose oculaire; Traitement; Treatment; Uveitis; Uvéite; Étude Delphi.

MeSH terms

  • Azithromycin / therapeutic use
  • Delphi Technique
  • Humans
  • Recurrence
  • Toxoplasmosis, Ocular* / diagnosis
  • Toxoplasmosis, Ocular* / epidemiology
  • Toxoplasmosis, Ocular* / therapy
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use

Substances

  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Azithromycin